Phase 3= 80% , EUA 20% based on the CD10 data and number of patients. We're blowing way too much smoke in the form of submitting to other countries to make you believe they are expecting good news from the FDA this week.

Been saying for awhile the CD12 was our ticket to the show and we really need to get 13 more patients enrolled and put some life or death data out that forces the FDA hand.